KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

91 hedge funds and large institutions have $237M invested in KalVista Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 13 closing their positions.

Holders
91
Holders Change
+2
Holders Change %
+2.25%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
17
Increased
36
Reduced
22
Closed
13
Calls
$6M
Puts
–
Net Calls
+$6M
Net Calls Change
+$4.33M

Top Buyers

1
TCM
1
Tang Capital Management
California
$17.7M
2
PVI
2
Pura Vida Investments
New York
$8M
3
GPP
3
Great Point Partners
Connecticut
$15.1M
4
WP
4
Woodline Partners
California
$10.7M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$11.1M

Top Sellers

1
IBT
1
International Biotechnology Trust
United Kingdom
$383K
2
RCM
2
RA Capital Management
Massachusetts
$0
3
Franklin Resources
3
Franklin Resources
California
$0
4
DM
4
Deerfield Management
New York
$0
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$4.63M
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
$1.71M 173,281 +110,311 +175%
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$1.42M 143,851 +130,427 +972%
Marshall Wace
28
Marshall Wace
United Kingdom
$1.32M 133,687 +97,328 +268%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$1.22M 123,622 +67,900 +122%
Millennium Management
30
Millennium Management
New York
$987K 100,317 +83,169 +485%
Nuveen Asset Management
31
Nuveen Asset Management
Illinois
$779K 79,243 +15,338 +24%
NFGH
32
Nan Fung Group Holdings
Hong Kong
$775K 78,720 – –
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$732K 74,400 +40,500 +119%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$719K 73,135 +3,565 +5%
HF
35
HRT Financial
New York
$676K 68,778 +68,778 New
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$648K 65,882 +42,989 +188%
Charles Schwab
37
Charles Schwab
California
$619K 62,899 +4,484 +8%
AC
38
Apogem Capital
New York
$609K 61,887 +18,157 +42%
Morgan Stanley
39
Morgan Stanley
New York
$584K 59,319 -8,060 -12%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$541K 54,976 +54,976 New
CL
41
CSS LLC
Illinois
$506K 51,399 -7,800 -13%
CSS
42
Cubist Systematic Strategies
Connecticut
$497K 50,514 +50,514 New
BC
43
Birchview Capital
Vermont
$394K 40,000 – –
TI
44
Trexquant Investment
Connecticut
$384K 39,048 +39,048 New
IBT
45
International Biotechnology Trust
United Kingdom
$383K 3,760 -379,473 -99%
GCP
46
GSA Capital Partners
United Kingdom
$380K 38,650 +15,148 +64%
Two Sigma Investments
47
Two Sigma Investments
New York
$369K 37,453 +37,453 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$341K 34,669 +12,519 +57%
First Trust Advisors
49
First Trust Advisors
Illinois
$306K 31,129 -760 -2%
EW
50
Evoke Wealth
California
$252K 25,583 – –
1
2
3 4 5